Metformin in cancer: translational challengesRyan J.O. Dowling, Pamela J. Goodwin|Journal of Molecular Endocrinology|2012Cited by 351
Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant studyRyan J.O. Dowling, Vuk Stambolic|Breast Cancer Research|2015Cited by 118
The role of mTOR signalling in translational control and cancerRyan J.O. Dowling|Library and Archives Canada (Government of Canada)|2009Cited by 0